Adverse impact of bleeding and transfusion on the outcome post-transcatheter aortic valve implantation: Insights from the Pooled-RotterdAm-Milano-Toulouse in Collaboration Plus (PRAGMATIC Plus) initiative

American Heart Journal

Volumn 164, Issue 3, 2012, Pages 402-409

  Tchetche, Didier ^a   Van Der Boon, Robert M A ^b   Dumonteil, Nicolas ^c   Chieffo, Alaide ^d   Van Mieghem, Nicolas M ^b   Farah, Bruno ^a   Buchanan, Gill L ^d   Saady, Redouane ^a   Marcheix, Bertrand ^c   Serruys, Patrick W ^b   Colombo, Antonio ^d   Carrie, Didier ^c   De Jaegere, Peter P T ^b   Fajadet, Jean ^a  

^a CLINIQUE PASTEUR   (France)

^b ERASMUS MEDICAL CENTER   (Netherlands)

^c CHU RANGUEIL   (France)

^d SAN RAFFAELE HOSPITAL   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ACUTE KIDNEY FAILURE; ADVERSE OUTCOME; AGED; ANEMIA; ARTICLE; CARDIOVASCULAR DISEASE; CARDIOVASCULAR MORTALITY; CONTROLLED STUDY; DISEASE SEVERITY; ERYTHROCYTE TRANSFUSION; FEMALE; FOLLOW UP; HEART LEFT VENTRICLE EJECTION FRACTION; HUMAN; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; PERIPHERAL VASCULAR DISEASE; POSTOPERATIVE HEMORRHAGE; PRIORITY JOURNAL; STROKE; SURVIVAL; TRANSCATHETER AORTIC VALVE IMPLANTATION; TRANSLUMINAL CORONARY ANGIOPLASTY; VASCULAR ACCESS;

ACUTE KIDNEY INJURY; AGED; AGED, 80 AND OVER; AORTIC VALVE; CARDIAC CATHETERIZATION; COHORT STUDIES; ERYTHROCYTE TRANSFUSION; FEMALE; HEART DEFECTS, CONGENITAL; HEART VALVE DISEASES; HEART VALVE PROSTHESIS IMPLANTATION; HUMANS; MALE; POSTOPERATIVE HEMORRHAGE; RETROSPECTIVE STUDIES; RISK FACTORS; STROKE; TREATMENT OUTCOME;

EID: 84866314261     PISSN: 00028703     EISSN: 10976744     Source Type: Journal    
DOI: 10.1016/j.ahj.2012.07.003     Document Type: Article

References (20)

1. A. Cribier, H. Eltchaninoff, and A. Bash Percutaneous transcatheter implantation of an aortic valve prosthesis for calcific aortic stenosis: first human case description Circulation 106 2002 3006 3008 (Pubitemid 35440280)
2. Kodali SK, Williams MR, Smith CR et al. Two-Year Outcomes after Transcatheter or Surgical Aortic-Valve Replacement. N Engl J Med.
3. Tamburino C, Capodanno D, Ramondo A et al. Incidence and predictors of early and late mortality after transcatheter aortic valve implantation in 663 patients with severe aortic stenosis. Circulation;123:299-308.
4. J.W. Eikelboom, S.R. Mehta, and S.S. Anand Adverse impact of bleeding on prognosis in patients with acute coronary syndromes Circulation 114 2006 774 782 (Pubitemid 44268228)
5. C.D. Joyner, R.J. Peters, and R. Afzal Fondaparinux compared to enoxaparin in patients with acute coronary syndromes without ST-segment elevation: outcomes and treatment effect across different levels of risk Am Heart J 157 2009 502 508
6. R. Mehran, S. Pocock, and E. Nikolsky Impact of bleeding on mortality after percutaneous coronary intervention results from a patient-level pooled analysis of the REPLACE-2 (randomized evaluation of PCI linking angiomax to reduced clinical events), ACUITY (acute catheterization and urgent intervention triage strategy), and HORIZONS-AMI (harmonizing outcomes with revascularization and stents in acute myocardial infarction) trials JACC Cardiovasc Interv 4 2011 654 664
7. Leon MB, Piazza N, Nikolsky E et al. Standardized endpoint definitions for transcatheter aortic valve implantation clinical trials: a consensus report from the Valve Academic Research Consortium. Eur Heart J;32:205-17.
8. Genereux P, Head SJ, Van Mieghem NM et al. Clinical Outcomes After Transcatheter Aortic Valve Replacement Using Valve Academic Research Consortium Definitions: A Weighted Meta-Analysis of 3,519 Patients From 16 Studies. J Am Coll Cardiol.
9. Tchetche D, Dumonteil N, Sauguet A et al. Thirty-day outcome and vascular complications after transarterial aortic valve implantation using both Edwards Sapien and Medtronic CoreValve bioprostheses in a mixed population. EuroIntervention;5:659-65.
10. Van Mieghem NM, Nuis RJ, Piazza N et al. Vascular complications with transcatheter aortic valve implantation using the 18 Fr Medtronic CoreValve System: the Rotterdam experience. EuroIntervention;5:673-9.
11. Godino C, Maisano F, Montorfano M et al. Outcomes after transcatheter aortic valve implantation with both Edwards-SAPIEN and CoreValve devices in a single center: the Milan experience. JACC Cardiovasc Interv;3:1110-21.
12. A. Vahanian, O. Alfieri, and N. Al-Attar Transcatheter valve implantation for patients with aortic stenosis: a position statement from the European Association of Cardio-Thoracic Surgery (EACTS) and the European Society of Cardiology (ESC), in collaboration with the European Association of Percutaneous Cardiovascular Interventions (EAPCI) Eur Heart J 29 2008 1463 1470 (Pubitemid 351806497)
13. V. Herbert Megaloblastic anemia as a problem in world health Am J Clin Nutr 21 1968 1115 1120
14. Gurvitch R, Toggweiler S, Willson AB et al. Outcomes and complications of transcatheter aortic valve replacement using a balloon expandable valve according to the Valve Academic Research Consortium (VARC) guidelines. EuroIntervention;7:41-8.
15. Nuis RJ, Piazza N, Van Mieghem NM et al. In-hospital complications after transcatheter aortic valve implantation revisited according to the Valve Academic Research Consortium definitions. Catheter Cardiovasc Interv;78:457-67.
16. G.W. Stone, H.D. White, and E.M. Ohman Bivalirudin in patients with acute coronary syndromes undergoing percutaneous coronary intervention: a subgroup analysis from the Acute Catheterization and Urgent Intervention Triage strategy (ACUITY) trial Lancet 369 2007 907 919 (Pubitemid 46400858)
17. Van Mieghem NM, Nuis RJ, Tzikas A et al. Prevalence and prognostic implications of baseline anaemia in patients undergoing transcatheter aortic valve implantation. EuroIntervention;7:184-91.
18. Bassand JP, Afzal R, Eikelboom J et al. Relationship between baseline haemoglobin and major bleeding complications in acute coronary syndromes. Eur Heart J;31:50-8.
19. Halliday BP, Dworakowski R, Brickham B, et al. Usefulness of periprocedural bleeding to predict outcome after transcatheter aortic valve implantation. Am J Cardiol;109:724-8.
20. G.L. Buchanan, A. Chieffo, and M. Montorfano The role of sex on VARC outcomes following transcatheter aortic valve implantation with both Edwards SAPIEN and Medtronic CoreValve ReValving System(R) devices: the Milan registry EuroIntervention 7 2011 556 563